These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 17363961)

  • 1. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families.
    Chen X; Wang X; O'Neill AF; Walsh D; Kendler KS
    Mol Psychiatry; 2004 Oct; 9(10):962-7. PubMed ID: 15124004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
    Sweet RA; Devlin B; Pollock BG; Sukonick DL; Kastango KB; Bacanu SA; Chowdari KV; DeKosky ST; Ferrell RE
    Mol Psychiatry; 2005 Nov; 10(11):1026-36. PubMed ID: 16027741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia.
    Wang Y; Fang Y; Shen Y; Xu Q
    Psychiatry Res; 2010 Sep; 179(2):147-50. PubMed ID: 20483479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk.
    Gellekink H; Muntjewerff JW; Vermeulen SH; Hermus AR; Blom HJ; den Heijer M
    Thromb Haemost; 2007 Dec; 98(6):1226-31. PubMed ID: 18064318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population.
    Nunokawa A; Watanabe Y; Muratake T; Kaneko N; Koizumi M; Someya T
    Neurosci Res; 2007 Jul; 58(3):291-6. PubMed ID: 17482701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
    Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R
    Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
    Chen CY; Yeh YW; Kuo SC; Ho PS; Liang CS; Yen CH; Lu RB; Huang SY
    Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.
    Borroni B; Grassi M; Costanzi C; Zanetti M; Archetti S; Franzoni S; Caimi L; Padovani A
    Neurobiol Aging; 2007 Aug; 28(8):1231-8. PubMed ID: 16837108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia.
    Strous RD; Lapidus R; Viglin D; Kotler M; Lachman HM
    Neurosci Lett; 2006 Jan; 393(2-3):170-3. PubMed ID: 16233957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
    Boot E; Booij J; Abeling N; Meijer J; da Silva Alves F; Zinkstok J; Baas F; Linszen D; van Amelsvoort T
    J Psychopharmacol; 2011 Jul; 25(7):888-95. PubMed ID: 21447540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMT val(158)met genotype and smooth pursuit eye movements in schizophrenia.
    Haraldsson HM; Ettinger U; Magnusdottir BB; Sigmundsson T; Sigurdsson E; Ingason A; Petursson H
    Psychiatry Res; 2009 Sep; 169(2):173-5. PubMed ID: 19647329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
    Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.
    Yamanouchi Y; Iwata N; Suzuki T; Kitajima T; Ikeda M; Ozaki N
    Pharmacogenomics J; 2003; 3(6):356-61. PubMed ID: 14610521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results.
    Zinkstok J; van Nimwegen L; van Amelsvoort T; de Haan L; Yusuf MA; Baas F; Linszen D
    Psychiatry Res; 2008 Jan; 157(1-3):1-8. PubMed ID: 17850881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
    Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
    Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R
    Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia.
    Illi A; Mattila KM; Kampman O; Anttila S; Roivas M; Lehtimäki T; Leinonen E
    J Clin Psychopharmacol; 2003 Oct; 23(5):429-34. PubMed ID: 14520117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.